半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體
Monoclonal Antibody to Cystatin C (Cys-C)
CST3; Cystatin 3; Gamma Trace; Post-Gamma-Globulin; Neuroendocrine Basic Polypeptide; Amyloid Angiopathy And Cerebral Hemorrhage
- 編號MAA896Hu26
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C9
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPA896Hu01-半胱氨酸蛋白酶抑制劑3(Cys-C)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應(yīng)用WB
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 594 ¥ 1386 ¥ 1980 ¥ 4950 ¥ 19800
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
IHC圖
-
Figure. Western Blot; Sample: Recombinant Cys-C, Human.
-
Western Blot; Sample: Lane1: Human Milk; Lane2: Human Urine
Primary Ab: 6μg/ml Mouse Anti-Human Cys-C Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對Cys-C的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別Cys-C。
用法
Western blotting: 0.01-6μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA896Hu61 | 半胱氨酸蛋白酶抑制劑3(Cys-C)活性蛋白 | Cell?culture;?Activity?Assays. |
| EPA896Hu61 | 半胱氨酸蛋白酶抑制劑3(Cys-C)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA896Hu71 | 半胱氨酸蛋白酶抑制劑3(Cys-C)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA896Hu22 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB; IHC |
| RAA896Hu21 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組抗體 | WB; IHC; ICC. |
| RAA896Hu22 | 半胱氨酸蛋白酶抑制劑3(Cys-C)重組抗體 | WB; IHC; ICC. |
| MAA896Hu24 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB,IHC |
| MAA896Hu25 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB |
| MAA896Hu26 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB |
| MAA896Hu21 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體 | WB,IHC |
| LAA896Hu74 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAA896Hu76 | 半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| FAA896Hu54 | 抗半胱氨酸蛋白酶抑制劑3(Cys-C)單克隆抗體(別藻藍蛋白標(biāo)記) | FCM |
| SEA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMA896Hu | 半胱氨酸蛋白酶抑制劑3(Cys-C)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| PSA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| KSA896Hu01 | 半胱氨酸蛋白酶抑制劑3(Cys-C)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| BioMed Research International | The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies [Hindawi: 740105] |
| Critical Care | Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein [Pubmed:25261195] |
| РОЛЬ АПОПТОЗ ИНДУЦИРУЮЩЕГО ФАКТОРА И ОКИСЛИТЕЛЬНОГО СТРЕССА ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ [616-005.8] | |
| Journal of Agricultural and Food Chemistry | Protective Effects of DHA-PC against Vancomycin-Induced Nephrotoxicity through the Inhibition of Oxidative Stress and Apoptosis in BALB/c Mice [pubmed:29254330] |
| THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | Association of cathepsin B and cystatin C with an age-related pulmonary subclinical state in a healthy Chinese population [Pubmed: 32401159] |
| RSC Adv | SERS based Y-shaped aptasensor for early diagnosis of acute kidney injury [Pubmed:35733690] |
| Food Funct | A Compared Study of Gentle Ketogenic Diet Containing Medium-Chain Triglycerides or Long-Chain Triglycerides on Chronic Sleep Deprivation-Induced Cognitive?… [Pubmed:35141738] |
留言咨詢
